BACKGROUND: Chronic rhinosinusitis (CRS) is strongly associated with comorbid asthma. This study compares early-onset and late-onset asthma in a CRS population using patient-reported and clinical characteristics. METHODS: At enrollment into a clinical registry, CRS patients completed the 22-item Sino-Nasal Outcome Test (SNOT-22), Asthma Control Test (ACT), mini-Asthma Quality of Life Questionnaire (miniAQLQ), the 29-item Patient-Reported Outcomes Measurement Information System (PROMIS-29), and medication use questionnaires. Patients also reported comorbid asthma and age at first asthma diagnosis. Early-onset (<18 years) and late-onset (>18 years) asthma groups were defined. Analysis of variance (ANOVA), chi-square, and Kruskal-Wallis tests were used to compare patient responses. RESULTS: A total of 199 non-asthmatic (56.1%), 71 early-onset asthmatic (20.0%), and 85 late-onset asthmatic (23.9%) CRS patients completed the survey. Body mass index (BMI) was significantly higher in late-onset asthmatic (p = 0.046) while age, gender, race, and smoking history did not differ with time of asthma onset. SNOT-22, ACT, and miniAQLQ were not different between asthma groups, but late-onset asthmatics had significantly lower physical function than non-asthmatics (p = 0.008). Compared to non-asthmatics, late-onset asthmatics showed increased rates of nasal polyps (p < 0.001), higher Lund-Mackay scores (p = 0.005), and had received more oral steroid courses (p < 0.001) and endoscopic surgeries (p = 0.008) for CRS management. Late-onset asthmatics compared to early-onset asthmatics showed increased nasal polyposis (p = 0.011) and oral steroid courses for CRS (p = 0.003). CONCLUSION: While CRS-specific and asthma-specific patient-reported outcome measures (PROMs) were not significantly different among groups, CRS patients with late-onset asthma had poorer physical function, more frequent nasal polyposis, and required increased treatment for CRS. Late-onset asthma may predict more severe disease in CRS.
BACKGROUND:Chronic rhinosinusitis (CRS) is strongly associated with comorbid asthma. This study compares early-onset and late-onset asthma in a CRS population using patient-reported and clinical characteristics. METHODS: At enrollment into a clinical registry, CRSpatients completed the 22-item Sino-Nasal Outcome Test (SNOT-22), Asthma Control Test (ACT), mini-Asthma Quality of Life Questionnaire (miniAQLQ), the 29-item Patient-Reported Outcomes Measurement Information System (PROMIS-29), and medication use questionnaires. Patients also reported comorbid asthma and age at first asthma diagnosis. Early-onset (<18 years) and late-onset (>18 years) asthma groups were defined. Analysis of variance (ANOVA), chi-square, and Kruskal-Wallis tests were used to compare patient responses. RESULTS: A total of 199 non-asthmatic (56.1%), 71 early-onset asthmatic (20.0%), and 85 late-onset asthmatic (23.9%) CRSpatients completed the survey. Body mass index (BMI) was significantly higher in late-onset asthmatic (p = 0.046) while age, gender, race, and smoking history did not differ with time of asthma onset. SNOT-22, ACT, and miniAQLQ were not different between asthma groups, but late-onset asthmatics had significantly lower physical function than non-asthmatics (p = 0.008). Compared to non-asthmatics, late-onset asthmatics showed increased rates of nasal polyps (p < 0.001), higher Lund-Mackay scores (p = 0.005), and had received more oral steroid courses (p < 0.001) and endoscopic surgeries (p = 0.008) for CRS management. Late-onset asthmatics compared to early-onset asthmatics showed increased nasal polyposis (p = 0.011) and oral steroid courses for CRS (p = 0.003). CONCLUSION: While CRS-specific and asthma-specific patient-reported outcome measures (PROMs) were not significantly different among groups, CRSpatients with late-onset asthma had poorer physical function, more frequent nasal polyposis, and required increased treatment for CRS. Late-onset asthma may predict more severe disease in CRS.
Authors: John A Burgess; E Haydn Walters; Graham B Byrnes; Melanie C Matheson; Mark A Jenkins; Cathryn L Wharton; David P Johns; Michael J Abramson; John L Hopper; Shyamali C Dharmage Journal: J Allergy Clin Immunol Date: 2007-09-07 Impact factor: 10.793
Authors: Wei Wu; Eugene Bleecker; Wendy Moore; William W Busse; Mario Castro; Kian Fan Chung; William J Calhoun; Serpil Erzurum; Benjamin Gaston; Elliot Israel; Douglas Curran-Everett; Sally E Wenzel Journal: J Allergy Clin Immunol Date: 2014-02-28 Impact factor: 10.793
Authors: D Jarvis; R Newson; J Lotvall; D Hastan; P Tomassen; T Keil; M Gjomarkaj; B Forsberg; M Gunnbjornsdottir; J Minov; G Brozek; S E Dahlen; E Toskala; M L Kowalski; H Olze; P Howarth; U Krämer; J Baelum; C Loureiro; L Kasper; P J Bousquet; J Bousquet; C Bachert; W Fokkens; P Burney Journal: Allergy Date: 2011-11-04 Impact factor: 13.146
Authors: John H Krouse; Maria C Veling; Matthew W Ryan; Harold C Pillsbury; Helene J Krouse; Stephanie Joe; Andrew J Heller; Joseph K Han; Stanley M Fineman; Randall W Brown Journal: Otolaryngol Head Neck Surg Date: 2007-05 Impact factor: 3.497
Authors: Robert A Nathan; Christine A Sorkness; Mark Kosinski; Michael Schatz; James T Li; Philip Marcus; John J Murray; Trudy B Pendergraft Journal: J Allergy Clin Immunol Date: 2004-01 Impact factor: 10.793
Authors: Dominick E Shaw; Ana R Sousa; Stephen J Fowler; Louise J Fleming; Graham Roberts; Julie Corfield; Ioannis Pandis; Aruna T Bansal; Elisabeth H Bel; Charles Auffray; Chris H Compton; Hans Bisgaard; Enrica Bucchioni; Massimo Caruso; Pascal Chanez; Barbro Dahlén; Sven-Erik Dahlen; Kerry Dyson; Urs Frey; Thomas Geiser; Maria Gerhardsson de Verdier; David Gibeon; Yi-Ke Guo; Simone Hashimoto; Gunilla Hedlin; Elizabeth Jeyasingham; Pieter-Paul W Hekking; Tim Higenbottam; Ildikó Horváth; Alan J Knox; Norbert Krug; Veit J Erpenbeck; Lars X Larsson; Nikos Lazarinis; John G Matthews; Roelinde Middelveld; Paolo Montuschi; Jacek Musial; David Myles; Laurie Pahus; Thomas Sandström; Wolfgang Seibold; Florian Singer; Karin Strandberg; Jorgen Vestbo; Nadja Vissing; Christophe von Garnier; Ian M Adcock; Scott Wagers; Anthony Rowe; Peter Howarth; Ariane H Wagener; Ratko Djukanovic; Peter J Sterk; Kian Fan Chung Journal: Eur Respir J Date: 2015-09-10 Impact factor: 16.671
Authors: Florian Jansen; Benjamin Becker; Jördis K Eden; Philippe C Breda; Amra Hot; Tim Oqueka; Christian S Betz; Anna S Hoffmann Journal: Eur Arch Otorhinolaryngol Date: 2022-10-15 Impact factor: 3.236
Authors: Mitesh P Mehta; Kevin Hur; Caroline P E Price; Stephanie Shintani-Smith; Kevin C Welch; David B Conley; Robert C Kern; Bruce K Tan Journal: Laryngoscope Investig Otolaryngol Date: 2021-09-18
Authors: Amarbir S Gill; Jess C Mace; Ryan Rimmer; Vijay R Ramakrishnan; Daniel M Beswick; Zachary M Soler; James Manor; Richard R Orlandi; Timothy L Smith; Jeremiah A Alt Journal: Int Forum Allergy Rhinol Date: 2021-07-14 Impact factor: 3.858
Authors: Amarbir S Gill; Kristine A Smith; Huong Meeks; Gretchen M Oakley; Karen Curtin; Laurie LeClair; Heather Howe; Richard R Orlandi; Jeremiah A Alt Journal: Int Forum Allergy Rhinol Date: 2021-02-24 Impact factor: 5.426